Preliminary Program subject to change
Molecular Modeling Throughout the Drug Discovery Process I
Presentation Type	Oral
Summary Statement
Presider:	Wendy D. Cornell, Merck & Co., Rahway, NJ
Introductory Remarks Protein Ensemble Docking: A Robust, General Strategy for Greatly Enhanced Lead Docking Daniel L. Cheney and Luciano Mueller, Bristol-Myers Squibb PRI, Hopewell, NJ Critical Assessment of Docking Programs and Scoring Functions Greg Warren, GlaxoSmithKline Pharmaceuticals, Collegeville, PA Intermission Rapid and Accurate Protein Side-Chain Prediction Michael Bower, Incyte Pharmaceuticals, Wilmington, DE An Ab Initio Method for Predicting the Stereochemistry of Drug Intermediates Using NMR Keith W. Wiitala, Christopher J. Cramer and Thomas R. Hoye, University of Minnesota, Minneapolis, MN

General Submissions